Literature DB >> 26037061

Investigating the origin and global dispersal history of hepatitis E virus genotype 4 using phylogeographical analysis.

Tatsunori Nakano1, Kazuaki Takahashi2, Masaharu Takahashi3, Yoichi Nishigaki4, Naoki Watanabe4, Satoshi Ishida5, Shino Fujimoto5, Hideaki Kato6, Hiroshi Okano7, Yoshiyuki Takei8, Minoru Ayada9, Eiichi Tomita4, Masahiro Arai2, Hiroaki Okamoto3, Shunji Mishiro2.   

Abstract

BACKGROUND & AIMS: Hepatitis E virus (HEV) genotype 4 has mainly been isolated from sporadic hepatitis cases and swine in Asian countries. We analysed the origin and global dispersal history of genotype 4 using a Bayesian phylogeographical approach.
METHODS: The 412-nucleotide sequences of open reading frame 2 of genotype 4 (47 Japanese, 40 Chinese, 1 Indian, 8 Indonesian, 1 Korean, 1 Taiwanese, 2 Danish and 2 Italian), of which sampling date and location were known, were collected. Evolutionary rate, divergence time, demographic growth and phylogeography were co-estimated in the Bayesian statistical inference framework implemented in the BEAST package to model spatial dispersal on a time-scaled genealogy.
RESULTS: The most probable origin of genotype 4 was Japan and the time of origin was 1909 (95% highest posterior density, 1871-1940). Seven lineages of genotype 4 migrated from Japan to China. The analysis also showed the migration of genotype 4 from Japan or China to India and Indonesia and from China to Indonesia, Taiwan, Korea and a few European countries.
CONCLUSIONS: Swine trade between countries coincided with the migration time and direction of genotype 4 in some cases and was considered the primary cause of dispersal. However, there was no clear cause of dispersal for some cases, for which no records of pig trade were found. Future research should analyse additional nucleotide sequences paired with epidemiological data from various countries to improve our understanding of HEV dispersal.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  genotype 4; hepatitis E virus; origin; phylogeographical analysis; swine trade

Mesh:

Substances:

Year:  2015        PMID: 26037061     DOI: 10.1111/liv.12880

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  7 in total

Review 1.  Development of new hepatitis E vaccines.

Authors:  Yufeng Cao; Zhenhong Bing; Shiyu Guan; Zecai Zhang; Xinping Wang
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

Review 2.  Swine hepatitis E virus: Cross-species infection, pork safety and chronic infection.

Authors:  Harini Sooryanarain; Xiang-Jin Meng
Journal:  Virus Res       Date:  2020-04-23       Impact factor: 3.303

3.  Detection of hepatitis E virus genotypes 3 and 4 in pig farms in Korea.

Authors:  Yong-Hyun Kim; Byung-Joo Park; Hee-Seop Ahn; Sang-Hoon Han; Hyeon-Jeong Go; Dong-Hwi Kim; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; Sang-Won Lee; In-Soo Choi
Journal:  J Vet Sci       Date:  2018-03-31       Impact factor: 1.672

4.  Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections.

Authors:  Claudia Minosse; Daniele Lapa; Antonio Coppola; Federica Rapagna; Gianpiero D'Offizi; Chiara Taibi; Raffaella Lionetti; Maria Rosaria Capobianchi; Fiona McPhee; Anna Rosa Garbuglia
Journal:  Viruses       Date:  2021-02-03       Impact factor: 5.048

5.  Detection and Characterization of Hepatitis E Virus in Goats at Slaughterhouse in Tai'an Region, China.

Authors:  Song Li; Mingxia Liu; Jingjing Cong; Yufa Zhou; Zengmin Miao
Journal:  Biomed Res Int       Date:  2017-12-12       Impact factor: 3.411

6.  Origin and dispersal of Hepatitis E virus.

Authors:  Diego Forni; Rachele Cagliani; Mario Clerici; Manuela Sironi
Journal:  Emerg Microbes Infect       Date:  2018-02-07       Impact factor: 7.163

7.  Comprehensive analysis of genetic and evolutionary features of the hepatitis E virus.

Authors:  Sarra Baha; Nouredine Behloul; Zhenzhen Liu; Wenjuan Wei; Ruihua Shi; Jihong Meng
Journal:  BMC Genomics       Date:  2019-10-29       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.